Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
12/05/2002 | WO2002097123A2 Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels |
12/05/2002 | WO2002097122A1 Secretion of proteins by encapsulated cells |
12/05/2002 | WO2002097121A1 Method for assaying osteoclast recruitment and resorption |
12/05/2002 | WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
12/05/2002 | WO2002097112A2 Catalytic amplification of multiplexed assay signals |
12/05/2002 | WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF |
12/05/2002 | WO2002097094A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
12/05/2002 | WO2002097079A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
12/05/2002 | WO2002097075A2 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties |
12/05/2002 | WO2002097060A2 Carbohydrate-associated proteins |
12/05/2002 | WO2002097059A2 Chromosome-based platforms |
12/05/2002 | WO2002097058A2 Genetic markers for improved disease resistance in animals (nramp1) |
12/05/2002 | WO2002097054A2 Shaped microcomponents via reactive conversion of biologically-derived microtemplates |
12/05/2002 | WO2002097051A2 Protein arrays and methods and systems for producing the same |
12/05/2002 | WO2002097049A2 Compositions and methods for binding agglomeration proteins |
12/05/2002 | WO2002097047A2 Compositions and methods for the inference of pigmentation traits |
12/05/2002 | WO2002097046A2 B7 related protein-2 molecules and uses thereof |
12/05/2002 | WO2002097045A2 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore |
12/05/2002 | WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
12/05/2002 | WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same |
12/05/2002 | WO2002097037A2 Melanin-concentrating hormone analogs |
12/05/2002 | WO2002097035A2 Secreted proteins |
12/05/2002 | WO2002097033A2 Antibodies that immunospecifically bind to trail receptors |
12/05/2002 | WO2002097032A2 Proteins associated with cell growth, differentiation, and death |
12/05/2002 | WO2002096977A1 Method of bonding substance to be incorporated to polymer terminal |
12/05/2002 | WO2002096951A1 Molecules for disease detection and treatment |
12/05/2002 | WO2002096950A1 Fxiii detection for verifying serum sample and sample size and for detecting dilution |
12/05/2002 | WO2002096942A2 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof |
12/05/2002 | WO2002096932A1 Transporters and ion channels |
12/05/2002 | WO2002096930A2 Iap binding peptides and assays for identifying compounds that bind iap |
12/05/2002 | WO2002096929A2 Polypeptides reacting with hcv-infected patients' antibodies and uses |
12/05/2002 | WO2002096926A1 Modulators of pharmacological agents |
12/05/2002 | WO2002096552A2 Biochip and apparatus and methods for its manufacture and use |
12/05/2002 | WO2002096468A2 Method for the diagnosis and therapy of renal cell carcinoma |
12/05/2002 | WO2002096364A2 Feline bronchioloalveolar lung carcinoma xenograft and cell line |
12/05/2002 | WO2002096292A1 Wrinkle indicator tape strip and method of using the same |
12/05/2002 | WO2002096284A1 Methods to diagnose treat and prevent bone loss |
12/05/2002 | WO2002096267A2 Noninvasive intraductal fluid diagnostic screen |
12/05/2002 | WO2002096266A2 Method and system for optically performing an assay to determine a medical condition |
12/05/2002 | WO2002096262A2 Non-alloying core shell nanoparticles |
12/05/2002 | WO2002096198A2 Methods for the identification of inhibitors of 3-oxo-5-alpha-steroid 4-dehydrogenase expression or activity in plants |
12/05/2002 | WO2002087499A9 Cells for detection of enteroviruses |
12/05/2002 | WO2002082505A3 A method to reduce leakage during a semi-conductor burn-in procedure |
12/05/2002 | WO2002082089A3 Anti-idiotypic antibody and its use in diagnosis and therapy of hepatitis c virus related diseases |
12/05/2002 | WO2002081415A3 Method for inhibiting metap2 |
12/05/2002 | WO2002079504A9 Neotic and endoapoptotic cells and detection of neosis and endoapoptosis |
12/05/2002 | WO2002078720A3 Antibiotics from bacteria isolated from amphibian skin |
12/05/2002 | WO2002070557A3 Nuclear hormone receptor ligand binding domain |
12/05/2002 | WO2002070018A3 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
12/05/2002 | WO2002068470A3 Interferon-alpha induced gene |
12/05/2002 | WO2002064797A9 Mitochondrial topoisomerase i |
12/05/2002 | WO2002062957A9 Ter sites and ter binding proteins |
12/05/2002 | WO2002061386A3 Marker for roscovitine |
12/05/2002 | WO2002061134A9 Reagents and methods for identifying and modulating expression of tumor senescence genes |
12/05/2002 | WO2002060924A9 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
12/05/2002 | WO2002060420A3 Utilization of a claudin-4 ligand and conjugates thereof in the therapy and diagnosis of tumors |
12/05/2002 | WO2002059150A3 Materials and methods relating to protein aggregation in neurodegenerative disease |
12/05/2002 | WO2002053749A3 Regulation of human serine-threonine protein kinase |
12/05/2002 | WO2002052257A3 Device and method for analyzing fat of meat |
12/05/2002 | WO2002050543A3 Free analyte detection system |
12/05/2002 | WO2002048705A3 Gas sensor calibration system |
12/05/2002 | WO2002046221A3 Human protein differentially expressed in alzheimer's disease's brain |
12/05/2002 | WO2002043572A3 Erythropoietin and erythropoietin receptor expression in human cancer |
12/05/2002 | WO2002038732A3 Human testis specific serine/threonine kinase |
12/05/2002 | WO2002037103A3 Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors |
12/05/2002 | WO2002028902A3 Nectin polypeptides, polynucleotides, methods of making and use thereof |
12/05/2002 | WO2002028351A9 Recombinant mucin binding proteins from steptococcus pneumoniae |
12/05/2002 | WO2002025278A3 Method for determining the peptide hormone activities or the steroid hormone activities of a material or substance mixture |
12/05/2002 | WO2002023198A3 Indirect method for the quantitative analysis of the binding capacity present in an aqueous protein solution |
12/05/2002 | WO2002010758A3 Surface-attached polyfunctional polymer networks for sensor chips |
12/05/2002 | WO2002010449A3 Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome |
12/05/2002 | WO2002006839A3 Blood group serological analysis method |
12/05/2002 | WO2002006453A3 Regulation of human desc1-like serine protease |
12/05/2002 | WO2002004955A3 Assay method and system for identification of p2y receptor agonists and antagonists |
12/05/2002 | WO2002000715A3 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
12/05/2002 | WO2001097608A3 Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods |
12/05/2002 | WO2001096596A3 Compositions containing a urea derivative dye for detecting an analyte |
12/05/2002 | WO2001092491A3 Mammalian protein phosphatases identified by in-silico analysis |
12/05/2002 | WO2001088180A3 Tnf and ifn stimulated genes and uses therefor |
12/05/2002 | WO2001085947A3 Compounds and methods for the diagnosis and treatment of babesia microti infection |
12/05/2002 | WO2001083518A9 Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same |
12/05/2002 | WO2001079448A3 Trp8, a transient receptor potential channel expressed in taste receptor cells |
12/05/2002 | WO2001067111A3 A collection system for storage and manipulation of a sample |
12/05/2002 | WO2001064949B1 Diagnostics and therapeutics for glaucoma |
12/05/2002 | WO2001063543A3 Method and system for the assembly of a whole genome using a shot-gun data set |
12/05/2002 | WO2001044816A9 Conformational and topological protein regulation |
12/05/2002 | WO2001038580A9 Nucleic acid probe arrays |
12/05/2002 | WO2001037231A3 Carbon monoxide detector for air vehicles |
12/05/2002 | WO2001032926A3 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
12/05/2002 | WO2001032685A9 Gene expression directed by a super-psa promoter |
12/05/2002 | WO2001027857A9 Methods for generating databases and databases for identifying polymorphic genetic markers |
12/05/2002 | WO2001021796A9 Gl50 molecules and uses therefor |
12/05/2002 | WO2001020329A9 Test systems and sensors for detecting molecular binding events |
12/05/2002 | US20020184656 In vivo assay system for screening and validation of drugs and other substances |
12/05/2002 | US20020183939 Measuring device for determining physical and chemical properties of gases , liquids and solids |
12/05/2002 | US20020183937 Method for the generation of proteins with new enzymatic function |
12/05/2002 | US20020183933 Computer-aided techniques for analyzing biological sequences |
12/05/2002 | US20020183600 Method and apparatus for detecting mastitis by using visual light and/or near infrared lights |
12/05/2002 | US20020183509 Generation of preferential nucleotide sequences library; obtain nucleotide sequences, denature, hybridize to primers, remove and recover nucleotide sequences expressing signal |
12/05/2002 | US20020183508 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |